Cleared Traditional

K160863 - PBS(-)

K160863 is an FDA 510(k) clearance for PBS(-), manufactured by Kitazato Biopharma Co;Ltd. The device is a Class 2 Obstetrics & Gynecology device with product code MQL cleared through the Traditional 510(k) pathway after a 121-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2016
Decision
121d
Days
Class 2
Risk

K160863 is an FDA 510(k) clearance for the PBS(-), Phosphate Buffered Saline. Classified as Media, Reproductive (product code MQL), Class II - Special Controls.

Submitted by Kitazato Biopharma Co;Ltd (Fuji, JP). The FDA issued a Cleared decision on July 28, 2016 after a review of 121 days - within the typical 510(k) review window.

This device falls under the Obstetrics & Gynecology FDA review panel, regulated under 21 CFR 884.6180 - the FDA obstetrics and gynecology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Obstetrics & Gynecology review framework, consistent with the majority of Class II 510(k) submissions.

View all Kitazato Biopharma Co;Ltd devices

FDA 510(k) Submission Details - K160863

510(k) Number K160863 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 29, 2016
Decision Date July 28, 2016
Days to Decision 121 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
39d faster than avg
Panel avg: 160d · This submission: 121d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MQL Device Classification - Class 2, Special Controls

Product Code MQL Media, Reproductive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 884.6180
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Obstetrics & Gynecology devices follow this clearance model.

Regulatory Peers - MQL Media, Reproductive

All 168
Devices cleared under the same product code (MQL) and FDA review panel - the closest regulatory comparables to K160863.
Continuous Single Culture -NX (CSCM-NX)
K170681 · Irvine Scientific Sales Co., Inc. · Jun 2017
Continuous Single Culture-NX Complete (CSCM-NXC)
K170602 · Irvine Scientific Sales Co., Inc. · Jun 2017
SAGE Vitrification Kit and SAGE Vitrification Warming Kit
K170560 · CooperSurgical, Inc. · Apr 2017
FreezeKit Cleave , ThawKit Cleave
K150950 · Vitrolife Sweden AB · Dec 2015
SPERMFREEZE SOLUTION
K113786 · Vitrolife Sweden AB · Oct 2012
CONTINUOUS SINGLE CULTURE COMPLETE
K121572 · Irvine Scientific Sales Co., Inc. · Jul 2012